Prosthetic Heart Valves

Chapter 32


Prosthetic Heart Valves



Heart valve diseases are common and may result from congenital, inflammatory, infectious, or degenerative causes. The decisions regarding how to surgically correct these valvular problems, how to follow the patients after surgery, and what problems to anticipate are addressed in this chapter.



1. What are important considerations in the preoperative evaluation and planning of patients who are to undergo valve repair or replacement?


    Patients who are advised to have valve surgery require careful preoperative planning and assessment. Cardiac catheterization to rule out coronary artery obstructions that might require bypass is advised in adults more than 40 years old. Dental evaluation to identify abscesses or other potential sources of postoperative valvular infection is advisable. Carotid ultrasound to exclude significant stenosis in patients with bruits or neurologic symptoms is often requested. Visualization of the aorta, often with computed tomography (CT) scan, to assess atherosclerosis at potential cannulation sites and root dimensions, may occasionally be required before valve replacement.


2. What types of prosthetic valves are used for valve replacement, and which ones are most commonly used in current practice?


    Representative bioprosthetic and mechanical heart valve types are shown in Figure 32-1 and discussed here.



    A stentless bioprosthesis is a bovine or porcine heart valve implanted without a frame. In the aortic position, the aortic root is used to attach the valve. The major advantage is that the size of the implanted valve can be larger, because no space is required for a supporting frame. Data suggest that left ventricular function is better protected by nonstented compared with stented valves. Anticoagulation is recommended for the first 3 months after implantation.


    A stented bioprosthesis has a wire frame that provides the structure for the biologic material. The biologic material is usually bovine or porcine pericardium, which is specially treated to reduce antigenicity. Anticoagulation is recommended for the first 3 months after implantation.


    A single tilting disc mechanical valve opens with a minor and major orifice. The disc material is polycarbonate. The first successful valve was the Bjork-Shiley valve, introduced in 1969. These valves are rarely used in current practice.


    A bileaflet mechanical valve has two semicircular discs. The disc material is polycarbonate. The first bileaflet valve was introduced in 1977 by St. Jude Medical. Bileaflet valves are the most common mechanical heart valves used in current practice.


    Transcatheter aortic valve implantation (TAVI) or transcatheter aortic valve replacement (TAVR) has been performed at investigational sites for nearly 10 years, mostly commonly in Europe. In the United States, it has recently been approved, though programs that can implant such valves must meet strict standards. It is intended for patients with severe aortic stenosis who are not good surgical candidates for conventional valve replacement. The valve is implanted via a transarterial (femoral or axillary) or transapical approach. In Europe, the valve may also be implanted by a direct aortic approach. Significant risks of serious adverse events, such as valve displacement, cardiac tamponade, myocardial infarction, stroke, or injury of the aorta or femoral or axillary artery, are associated with this procedure. The procedure is illustrated in Figure 32-2.



    The ball-in-cage model is an older type of valve that is still encountered in some patients today. The Starr-Edwards mechanical valve prosthesis was introduced by Professor Albert Starr in 1961. It was the first mechanical heart valve. Some patients still have functioning Starr-Edwards prostheses after more than 30 years. The main drawback of this valve is its high-pressure gradient and the nonphysiologic streaming of flow through the valve. For these reasons, as well as the need for higher degrees of anticoagulation, the valve is no longer used in clinical practice.


3. What is a heterograft, and what is an allograft (homograft), and what is a Ross procedure?


    A heterograft is a biologic valve derived from an animal. An allograft (also called a homograft) is a heart valve taken from a human cadaver. Allografts have the advantage of natural configuration and the fact that they include a portion of the aortic root that can be incorporated in the valve replacement procedure if necessary (e.g., aortic root abscess). Careful matching of allograft size to the patient is critical to the performance and durability of the valve. The Ross procedure uses the patient’s own pulmonic valve to replace their aortic valve. The pulmonic valve is then replaced with a bioprosthesis. Advantages are a lack of antigenicity and the potential for growth of the valve over time, as required in children.


4. How does one choose between bioprosthetic and mechanical valves?

Stay updated, free articles. Join our Telegram channel

Jun 5, 2016 | Posted by in CARDIOLOGY | Comments Off on Prosthetic Heart Valves

Full access? Get Clinical Tree

Get Clinical Tree app for offline access